Immunic, Inc. Recorded Big Gain
Mon, Oct 10, 2022 at 07:01 PM
Immunic, Inc. (IMUX:NASDAQ) soared at $6.2, representing a gain of 56.6%. On Mon, Oct 10, 2022, IMUX:NASDAQ hit a New 2-Week High of $6.2. The stock got featured on our News Catalysts scanner on Mon, Oct 10, 2022 at 07:33 AM in the 'PRIVATE PLACEMENT' category. From Mon, Sep 26, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days
About Immunic, Inc. (IMUX:NASDAQ)
Vital Therapies Inc is a biotherapeutic company. It is involved in the business of developing liver treatment to improve survival in patients with Liver failure by providing hepatic support continuously for up to five days. The firm's main product candidate is ELAD system. It also owns VTL C3A cell bank which supports ELAD system.
Top 10 Gainers:
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 70.97%
- Immunic, Inc. (IMUX:NASDAQ), 56.57%
- Green Giant Inc Com (New) (GGE:NASDAQ), 39.26%
- Intelligent Living Application Group Inc. (ILAG:NASDAQ), 29.65%
- Concord Medical Services Holdings Limited (CCM:NYSE), 22.22%
- Universe Pharmaceuticals Inc (UPC:NASDAQ), 21.95%
- AEA-Bridges Impact Corp. Class A (IMPX:NYSE), 20.69%
- Recon Technology, Ltd. (RCON:NASDAQ), 19.88%
- Terran Orbital Corporation (LLAP:NYSE), 19.49%
- Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ), 18.88%